US

Antibodies grabs funding

UK-based Antibodies.com, a digital marketplace that enables life scientists to purchase critical research reagents from primary manufacturers, has raised 400,000 pounds in funding. The investors included Nidobirds Ventures.

DDF taps Behr as partner

The Dementia Discovery Fund, the venture fund that invests in projects and companies that develop treatments for age-related dementias, has named Dr. Jonathan Behr as a partner. Previously, he worked at the JDRF T1D Fund. SV Health Investors manages DDF.

Polyrize nets $4 mln seed

Polyrize, a new cybersecurity company, has raised $4 million in seed funding. Glilot Capital Partners led the round.

Horizon provides $8 mln venture loan to OutboundEngine

Horizon Technology Finance Corporation has provided a $8 million venture loan to OutboundEngine Inc. The capital will be used for growth and corporate purposes. Headquartered in Austin, Texas, OutboundEngine is a provider of B2B marketing automation software for small business owners. OutboundEngine's backers include Silverton Partners, S3 Ventures, Noro-Moseley Partners, Harmony Partners and Floodgate Fund.

Immunicom picks up $11 mln Series B

Immunicom Inc, a biotechnology company focused on treating late-stage metastatic cancer, has raised $11 million in Series B funding. The investors were several unnamed private equity family offices.

Vertex Ventures raised $150 mln second US fund

Epidemic Sound inks $20 mln

Epidemic Sound, a Swedish music provider, has secured $20 million in funding. The investors included DS Asset Management.

Greycroft leads funding round for Mercato

Mercato, an online ordering and delivery platform for independent grocery stores, has secured an undisclosed amount of funding. Greycroft led the round.

Clause inks $5.5 mln Series A

Clause, a provider of smart contracting technology, has raised $5.5 million in Series A funding. Galaxy Digital led the round.

Saluda Medical takes in $75 mln

Saluda Medical Pty, an Australian medical device company, has secured $75 million in financing. The investors were Boston Scientific Corporation and Redmile Group LLC.